PLSE PULSE BIOSCIENCES, INC.

8-K Current Report

Filed: March 9, 2026

Health Care

Surgical & Medical Instruments & Apparatus

PULSE BIOSCIENCES, INC. (PLSE) 8-K current report filed with SEC EDGAR on March 9, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• 21-patient study showed avg 74% volume reduction in benign thyroid nodules at 15-22 month follow-up — strong durability signal
• Zero nodule regrowth and zero serious adverse events through 22 months — clean long-term safety/efficacy profile

+3 more insights

Other PULSE BIOSCIENCES, INC. 8-K Filings

Get deeper insights on PULSE BIOSCIENCES, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.